CompareComparison

Is TipRanks Worth It? A 2026 Review

What a TipRanks subscription gives you, what the evidence says about following top analysts, what it leaves out, and the tool we recommend for putting analyst rankings next to your own portfolio’s risk.

Disclosure: Exent publishes this page and makes one of the products discussed. Facts about other products are checked on their own sites and dated. Our editorial policy explains how.

Key takeaways

  • TipRanks ranks experts and scores stocks for roughly $360–$600 a year (2026 third-party reviews). For analyst rankings checked against your own portfolio’s risk, Exent is our recommendation.
  • TipRanks says it tracks and ranks 96,000+ experts, including analysts, bloggers, hedge funds and insiders, and gives every stock a 1–10 Smart Score.
  • Analyst skill varies widely: in Exent’s 7-year data, 5★ analysts reached a median 60.8% of price targets vs 52.4% across all ratings.
  • A score on every stock is a starting point, not a decision; it says nothing about how a stock fits the portfolio you already own.

What do you get with TipRanks?

A ranking of experts and a score for every stock. TipRanks says it tracks and ranks over 96,000 financial experts by the accuracy of their past predictions, across Wall Street analysts, financial bloggers, corporate insiders and hedge fund managers.

  • Star Ranking: combines success rate, average return and statistical significance. The method covers ratings since January 2009. “Top Analysts” are the top 20% to 30%.
  • Smart Score: a 1–10 score built from eight inputs, from analyst ratings and insider transactions to technicals and fundamentals.
  • Paid tiers: Plus, Premium and Ultimate.

How much does TipRanks cost?

Roughly $360 to $600 a year for Premium and Ultimate, based on 2026 third-party reviews; TipRanks did not show prices on its plans page when we checked in October 2026, and discounts are frequent. Yearly plans carry a 30-day money-back guarantee.

Does following top‑ranked analysts help?

It can narrow the field, because analysts are far from equal, but the average call is close to a coin flip. Exent’s data on 628,792 ratings over 7 years (analyst stats as of June 24, 2026) shows the gap between the best-rated analysts and the rest:

GroupPrice-target hit rateCalls up 12 months later
5★ analysts (median of 141)60.8%68.6%
4★ analysts (median of 853)52.8%62.8%
All 628,792 ratings52.4%64.0%

Two cautions apply to any ranking. Past accuracy does not guarantee future accuracy. And analysts lean heavily positive: in the last 12 months of that data there were 115,187 Buy ratings against 4,536 Sell ratings, so a “Strong Buy” consensus is common. Accuracy also differs by sector: the median analyst’s hit rate ranged from 62.3% in materials to 37.3% in real estate. More in how to follow Wall Street analysts.

What does TipRanks leave out?

  • Portfolio fit. A strong call on a stock you already own through three ETFs adds risk, not diversification. Stock-level scores do not show that. See ETF overlap.
  • Crash exposure. Replaying your whole portfolio through 2008, 2020 or 2022 is not its focus.
  • A fair benchmark. Comparing your return with a portfolio of similar risk is not part of the Smart Score.
  • Open pricing. Prices are not listed openly and vary with promotions.

How does it compare with the alternatives?

ToolMain focusAnalyst track recordsCrash replay on your portfolioPrice (Oct 2026)
ExentAnalyst rankings and Gems, plus portfolio risk diagnosis and market regimeYes: thousands of analysts ranked by past accuracyYes: 2008, 2018, 2020, 2022, 2025Paid, with a short trial
TipRanks Premium / UltimateExpert rankings, Smart ScoreYesNot a focusAbout $360–$600/yr (third-party figures)
WallStreetZen PremiumZen Ratings, 4,000+ analysts trackedYesNot a focus$19.50/mo billed yearly
Seeking Alpha PremiumArticles, transcripts, Quant RatingsAuthor rating historyNot a focus$299/yr plus tax
Morningstar InvestorFund research, fair value estimatesNot a focusNot a focus$249/yr or $34.95/mo
  • Exent
    Main focus
    Analyst rankings and Gems, plus portfolio risk diagnosis and market regime
    Analyst track records
    Yes: thousands of analysts ranked by past accuracy
    Crash replay on your portfolio
    Yes: 2008, 2018, 2020, 2022, 2025
    Price (Oct 2026)
    Paid, with a short trial
  • TipRanks Premium / Ultimate
    Main focus
    Expert rankings, Smart Score
    Analyst track records
    Yes
    Crash replay on your portfolio
    Not a focus
    Price (Oct 2026)
    About $360–$600/yr (third-party figures)
  • WallStreetZen Premium
    Main focus
    Zen Ratings, 4,000+ analysts tracked
    Analyst track records
    Yes
    Crash replay on your portfolio
    Not a focus
    Price (Oct 2026)
    $19.50/mo billed yearly
  • Seeking Alpha Premium
    Main focus
    Articles, transcripts, Quant Ratings
    Analyst track records
    Author rating history
    Crash replay on your portfolio
    Not a focus
    Price (Oct 2026)
    $299/yr plus tax
  • Morningstar Investor
    Main focus
    Fund research, fair value estimates
    Analyst track records
    Not a focus
    Crash replay on your portfolio
    Not a focus
    Price (Oct 2026)
    $249/yr or $34.95/mo

Why we recommend Exent

Because it puts analyst accuracy and portfolio risk in one place. Stocks Radar ranks thousands of Wall Street analysts by past accuracy, with profiles, price targets and insider, congress and 13F views. Gems are the stocks where several analysts rated 4★ and above agree. Public rankings are on the analyst pages.

Portfolio Analysis then checks what you already own: upload a screenshot or file, with no brokerage login, and Exent measures concentration through correlation clusters, replays the portfolio through past crashes and compares it with a risk-matched benchmark. See Exent vs TipRanks and TipRanks alternatives.

How to check analyst calls against your portfolio with Exent

  1. Stocks Radar ranks thousands of Wall Street analysts by past accuracy and shows Gems, where several top‑rated analysts agree.
  2. Upload a screenshot of your holdings, or a CSV, Excel, PDF or Google Sheet; no brokerage login.
  3. Exent shows analysts and insiders on your holdings, replays the portfolio through past crashes, and lets you test a new idea in the what‑if simulator.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

It buys expert rankings and a Smart Score on every stock. If you want analyst rankings alongside a risk check of your own portfolio, Exent covers both in one place.

TipRanks did not list prices on its plans page in October 2026. Third-party reviews in 2026 put Premium and Ultimate at roughly $360 to $600 a year, with frequent discounts.

It is a 1 to 10 summary of eight inputs, from analyst ratings to technicals and fundamentals. Treat it as a starting point for research rather than a buy or sell signal.

TipRanks offers a 30-day money-back guarantee when you buy or upgrade a yearly plan.

Ranking helps because analyst skill varies widely; in Exent’s 7-year data, 5-star analysts reached a median 60.8% of price targets against 52.4% for all ratings. Past accuracy does not guarantee future results.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full Gems access· full Gems access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.